A US-European pharma joint venture launching a new prescription drug with lenalidomide for adults with certain diffuse large B-cell lymphomas built pre-launch customer insights using Indegene's robust analytics infrastructure. Challenges included creating analytics from scratch for an unlaunched brand, non-standardized tag management, decentralized reporting wasting resources, and missing channel insights hindering campaign tracking. Indegene's software standardized tagging, centralized data processing, and delivered comprehensive analytics from the ground up, empowering data-driven decisions, performance optimization, and strategic pre-launch positioning.

Join for free to read